Clinical Trial Update: A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that the investigational drug BPI-1178 is being studied in a Phase 1/2 trial for patients with advanced solid tumors and HR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BPI-1178

Snippet

Sponsor: Beta Pharma (Suzhou) Co., Ltd. | Conditions: Advanced Solid Tumor, HR+/HER2- Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING